Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Future studies should focus on conducting trials to provide more robust evidence on the comparative effectiveness of liraglutide and semaglutide in managing WR post-bariatric surgery
The peptide drug class encompasses everything from blockbuster GLP-1 receptor agonists prescribed to millions of patients, to emerging compounds still building their evidence base in clinical research
Dont be surprised if your levels are higher than expected
Glutathione is not just a beauty trend